Krystal Biotech (KRYS) Free Cash Flow (2016 - 2026)
Krystal Biotech recorded quarterly Free Cash Flow of $73.2 million in Q1 2026, down 2.44% quarter-over-quarter from $75.1 million in Q4 2025, and up 147.65% year-over-year from $29.6 million in Q1 2025.
Krystal Biotech's Free Cash Flow history runs 11 years deep, the most recent figure standing at $73.2 million for Q1 2026.
- In Q1 2026, Free Cash Flow rose 147.65% year-over-year to $73.2 million; the TTM figure through Mar 2026 stood at $241.5 million (up 70.86% YoY), while the FY2025 annual figure was $197.8 million, up 65.96% from the prior year.
- Free Cash Flow came in at $73.2 million for Q1 2026 at Krystal Biotech, down from $75.1 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $75.1 million in Q4 2025 to a low of -$62.3 million in Q2 2022.
- A 5-year average of $10.4 million and a median of $1.9 million in 2024 frame the typical range for Free Cash Flow.
- Across the five-year window, Free Cash Flow slumped 1557.42% in 2023 and jumped 2325.83% in 2025, its largest moves.
- Krystal Biotech's Free Cash Flow stood at -$22.0 million in 2022, then soared by 78.45% to -$4.7 million in 2023, then surged by 1200.02% to $52.0 million in 2024, then soared by 44.24% to $75.1 million in 2025, then slipped by 2.44% to $73.2 million in 2026.
- According to Business Quant data, Free Cash Flow over the past three periods registered $73.2 million, $75.1 million, and $47.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -1.67 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | -12.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | -2.49 Mn |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1.29 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 848.30 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 48.67 Mn |
| 10 | Krystal Biotech | 9.05 Bn | 8.23 Bn | 110.03 Mn | 73.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 73.23 Mn |
| Mar 31, 2026 | 73.23 Mn |
| Dec 31, 2025 | 75.06 Mn |
| Dec 31, 2025 | 75.06 Mn |
| Sep 30, 2025 | 47.14 Mn |
| Sep 30, 2025 | 47.14 Mn |
| Jun 30, 2025 | 46.02 Mn |
| Jun 30, 2025 | 46.02 Mn |
| Mar 31, 2025 | 29.57 Mn |
| Mar 31, 2025 | 29.57 Mn |
| Dec 31, 2024 | 52.04 Mn |
| Dec 31, 2024 | 52.04 Mn |
| Sep 30, 2024 | 57.81 Mn |
| Sep 30, 2024 | 57.81 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Jun 30, 2024 | 1.90 Mn |
| Mar 31, 2024 | 7.43 Mn |
| Mar 31, 2024 | 7.43 Mn |
| Dec 31, 2023 | -4.73 Mn |
| Dec 31, 2023 | -4.73 Mn |
| Sep 30, 2023 | -21.33 Mn |
| Sep 30, 2023 | -21.33 Mn |
| Jun 30, 2023 | -33.32 Mn |
| Jun 30, 2023 | -33.32 Mn |
| Mar 31, 2023 | -38.02 Mn |
| Mar 31, 2023 | -38.02 Mn |
| Dec 31, 2022 | -21.95 Mn |
| Dec 31, 2022 | -21.95 Mn |
| Sep 30, 2022 | -1.29 Mn |
| Sep 30, 2022 | -1.29 Mn |
| Jun 30, 2022 | -62.26 Mn |
| Jun 30, 2022 | -62.26 Mn |
| Mar 31, 2022 | -30.00 Mn |
| Mar 31, 2022 | -30.00 Mn |
| Dec 31, 2021 | -8.81 Mn |
| Dec 31, 2021 | -8.81 Mn |
| Sep 30, 2021 | -28.25 Mn |
| Sep 30, 2021 | -28.25 Mn |
| Jun 30, 2021 | -13.98 Mn |
| Jun 30, 2021 | -13.98 Mn |
| Mar 31, 2021 | -12.27 Mn |
| Mar 31, 2021 | -12.27 Mn |
| Dec 31, 2020 | -15.23 Mn |
| Dec 31, 2020 | -15.23 Mn |
| Sep 30, 2020 | -10.96 Mn |
| Sep 30, 2020 | -10.96 Mn |
| Jun 30, 2020 | -7.21 Mn |
| Jun 30, 2020 | -7.21 Mn |
| Mar 31, 2020 | -7.53 Mn |
| Mar 31, 2020 | -7.53 Mn |
| Dec 31, 2019 | -12.37 Mn |
| Dec 31, 2019 | -12.37 Mn |
| Sep 30, 2019 | -4.98 Mn |
| Sep 30, 2019 | -4.98 Mn |
| Jun 30, 2019 | -4.26 Mn |
| Jun 30, 2019 | -4.26 Mn |
| Mar 31, 2019 | -3.48 Mn |
| Mar 31, 2019 | -3.48 Mn |
| Dec 31, 2018 | -4.82 Mn |
| Dec 31, 2018 | -4.82 Mn |
| Sep 30, 2018 | -2.77 Mn |
| Sep 30, 2018 | -2.77 Mn |
| Jun 30, 2018 | -1.62 Mn |
| Jun 30, 2018 | -1.62 Mn |
| Mar 31, 2018 | -2.37 Mn |
| Mar 31, 2018 | -2.37 Mn |
| Dec 31, 2017 | -2.29 Mn |
| Dec 31, 2017 | -2.29 Mn |
| Sep 30, 2017 | -1.11 Mn |
| Sep 30, 2017 | -1.11 Mn |
| Jun 30, 2017 | -440,000.00 |
| Jun 30, 2017 | -440,000.00 |
| Mar 31, 2017 | -264,000.00 |
| Mar 31, 2017 | -264,000.00 |
| Dec 31, 2016 | -870,000.00 |
| Dec 31, 2016 | -870,000.00 |